{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Incyte", "item": "https://www.patentleaderboard.com/company/incyte"}, {"@type": "ListItem", "position": 3, "name": "Paul Smith", "item": "https://www.patentleaderboard.com/inventor/fl:pa_ln:smith-100"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Incyte › Paul Smith
PS

Paul Smith — 12 Patents

INIncyte: 9 patents #106 of 515Top 25%
USUcb Biopharma Srl: 2 patents #145 of 349Top 45%
Novartis Ag: 1 patents #2,882 of 5,128Top 60%
Wilmington, DE: #392 of 3,182 inventorsTop 15%
Delaware: #765 of 7,163 inventorsTop 15%
Overall (All Time): #396,045 of 4,157,543Top 10%
12 Patents All Time
Paul Smith has been granted 12 US patents while listed as an inventor at Incyte. The first was granted in 2019 and the most recent in April 2025. Paul Smith ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Paul Smith in Wilmington, DE, US.

Patents per Year

Patents granted per year, 2019 to 2025Bar chart with a peak of 5 patents in 2024.peak 52019: 1 patents20192020: 1 patents20202022: 2 patents20222023: 1 patents20232024: 5 patents20242025: 2 patents2025

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12280054 Treatment of hidradenitis suppurativa using JAK inhibitors Michael Howell 2025-04-22
12268667 JAK1 pathway inhibitors for the treatment of prurigo nodularis Kurt Andrew Brown 2025-04-08
12150943 JAK1 pathway inhibitors for the treatment of gastrointestinal disease Krishnaswamy Yeleswaram, Gregory F. Hollis 2024-11-26 $37,065,000
12005067 JAK inhibitor with a vitamin D analog for treatment of skin diseases Zheng ZHANG, Melissa Parker, James FIDGE 2024-06-11 $44,848,000
11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP) Jörg Wenzel 2024-05-28 $80,854,000
11957661 JAK1 pathway inhibitors for the treatment of vitiligo Kurt Andrew Brown, Michael Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos +1 more 2024-04-16 $36,460,000
11918581 Combination therapy comprising JAK pathway inhibitor and rock inhibitor Michael Peel 2024-03-05 $19,783,000
11596632 JAK1 pathway inhibitors for the treatment of gastrointestinal disease Krishnaswamy Yeleswaram, Gregory F. Hollis 2023-03-07 $49,850,000
11466324 Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy Adam Samuel Platt, Stephen Edward Rapecki, Mara Fortunato, David Robert Rainey, Jon Leigh Rundle +1 more 2022-10-11
11304949 Treatment of hidradenitis suppurativa using JAK inhibitors Michael Howell 2022-04-19 $53,989,000
10537566 Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis — 2020-01-21 $12,199,000
10208349 Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy Adam Samuel Platt, Stephen Edward Rapecki, Mara Fortunato, David Robert Rainey, Jon Leigh Rundle +1 more 2019-02-19

Frequent Collaborators

Michael Howell3 shared
Mara Fortunato2 shared
Gregory F. Hollis2 shared
Jon Leigh Rundle2 shared
Stephen Edward Rapecki2 shared
Krishnaswamy Yeleswaram2 shared

Nearby-Ranked Inventors

John Patrick Hickey, III12
Gregory Lutter12
Josselin Xavier COUPARD12
Xuan Li12
Nandana Mihindukulasooriya12
Keiichi Matsuda12
Robert Imig12
Peter Mage12
Sze Ping Ching12